title: Subconjunctival bevacizumab for iris neovascularisation.
authors.affiliation: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 308433, Singapore. Electronic address: vyip82@yahoo.co.uk.
authors.forename: Vivien C
authors.initials: VC
authors.lastname: Yip
authors.affiliation: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 308433, Singapore.
authors.forename: Leonard W
authors.initials: LW
authors.lastname: Yip
authors.affiliation: National Healthcare Group Eye Institute, Tan Tock Seng Hospital, 308433, Singapore.
authors.forename: Augustinus
authors.initials: A
authors.lastname: Laude
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A